No Data
No Data
The tariff war between the US and Europe is escalating, and Trump's 'tariff big stick' is making the pharmaceutical industry tremble.
Pharmaceutical companies are urging the Trump administration and EU officials to exclude Medical products from the escalation of the trade war.
Express News | US FDA: Some Lots of Immune Globulin Intravenous and Immune Globulin Subcutaneous Voluntarily Withdrawn by Grifols and ADMA Biologics -Website
Grifols Price Target Raised to EUR 11 From EUR 10 at Deutsche Bank
Grifols Responds to 'Misleading Media Report'
CFO: Grifols Planning Return to Public Debt Markets
Grifols Aims to Double Revenue Over Next Decade